Filing Analysis
Chain Bridge I shareholders approved a special resolution to extend the deadline for completing a business combination from November 15, 2025, to November 15, 2026. This extension provides the SPAC an additional year to find a target and avoid mandatory liquidation.
🚩 Red Flags
- The company is operating under a deadline to find a merger target; failure to do so by Nov 2026 results in liquidation.
- Significant redemption event occurred (393,146 shares), reducing the available capital in the Trust Account.
- SPAC structure inherently carries high risk of total loss of principal if no business combination is consummated.
📋 Key Facts
- Shareholders approved an amendment to extend the 'Extended Termination Date' from Nov 15, 2025, to Nov 15, 2026.
- The amendment removes limitations on redemptions/consummations caused by net tangible assets falling below $5,000,001.
- 393,146 Class A Shares were redeemed for approximately $4,721,683 in cash from the Trust Account.
- Fulton AC I LLC will contribute $625.90 per month to the Trust Account starting Nov 16, 2025.
- Post-redemption outstanding shares: 2,621,590 Class A Ordinary Shares and 3,191,000 Class B Ordinary Shares.
Chain Bridge I issued a $1.25 million unsecured, non-interest bearing promissory note to C/M Capital Master Fund LP on September 30, 2025, for an aggregate purchase price of $1.0 million. The funds are intended for business combination expenses and general corporate purposes.
🚩 Red Flags
- High-interest/Discounted debt: The company is receiving $1M for a $1.25M liability, indicating significant cost of capital.
- Restrictive Covenant: Failure to authorize new preferred shares by November 15, 2025, triggers an Event of Default.
- Lender Conversion Right: The Lender has the right to exchange the Note for 'New Preferred Shares' on mutually agreed terms, which could lead to significant dilution.
📋 Key Facts
- Issued a $1,250,000 unsecured, non-interest bearing promissory note to C/M Capital Master Fund LP.
- The Note was issued at a discount; the aggregate purchase price is $1,000,000.
- Maturity date is set for June 30, 2026.
- Proceeds are earmarked for fees and expenses related to the company's initial business combination and general corporate purposes.
- The Note includes a covenant requiring the Company to establish and authorize a new series of preferred shares by November 15, 2025.
Chain Bridge I entered into a contribution agreement with Fulton AC I LLC to fund monthly capital contributions to the company's trust account. This is part of an effort to extend the company's termination date from November 15, 2025, to November 15, 2026, to allow more time to complete a business combination.
🚩 Red Flags
- SPAC survival mechanism: The company is relying on monthly cash injections from a related party to maintain its trust account and avoid liquidation.
- Liquidation risk: If the extension is not approved or if Fulton AC ceases contributions, the company will wind up and liquidate.
📋 Key Facts
- Fulton AC I LLC will contribute $0.01 per Public Share remaining outstanding (not redeemed) on the 16th of each month starting November 16, 2025.
- The purpose is to fund the Trust Account following a proposed amendment to extend the company's existence until November 15, 2026.
- A shareholder meeting is scheduled for October 29, 2025, to vote on the extension and removal of certain redemption limitations.
- Fulton AC will receive capital stock or convertible securities in the surviving entity upon consummation of an Initial Business Combination as consideration for these contributions.
Chain Bridge I entered into a non-binding Letter of Intent (LOI) to pursue a business combination with CommLoan, Inc., a commercial real estate lending technology company. The transaction would result in the combined entity being named CommLoan Inc., led by CEO Mitch Ginsberg, and is expected to list on the Nasdaq Capital Market.
🚩 Red Flags
- The LOI is non-binding, meaning there is no guarantee a definitive agreement will be reached or the deal will close.
- Potential for significant shareholder redemptions could deplete the trust account before closing.
- Transaction is subject to shareholder approval and financing contingencies.
📋 Key Facts
- Entered into a non-binding Letter of Intent (LOI) with CommLoan, Inc. on September 8, 2025.
- CommLoan equity holders would exchange 100% of their equity for equity in the combined public company.
- The combined entity is expected to be named 'CommLoan Inc.' and led by founder/CEO Mitch Ginsberg.
- Targeted listing: Nasdaq Capital Market.
- Expected timeline: Definitive agreement in Q4 2025; closing anticipated in H1 2026.
Chain Bridge I is amending its previous 8-K to provide an auditor's letter following the termination of Frank, Rimerman + Co. LLP and the appointment of RBSM, LLP. The filing confirms a prior restatement due to a $200,000 error in a promissory note liability and acknowledges a material weakness in internal controls over financial reporting.
🚩 Red Flags
- Auditor change combined with a prior restatement (Red Flag Escalator).
- Material weakness in internal controls over financial reporting.
- Requirement to restate previous quarterly filings (Non-Reliance Period).
- Error involving understatement of liabilities and overstatement of net income.
📋 Key Facts
- Terminated Frank, Rimerman + Co. LLP as independent auditor effective April 4, 2025.
- Engaged RBSM, LLP as the new independent registered public accounting firm for fiscal year 2024.
- Confirmed a $200,000 understatement of a promissory note liability (Bridge Financing Note) issued to Phytaix Bio on June 26, 2024.
- The error resulted in understated general and administrative expenses and overstated net income for the periods ended September 30, 2024.
- Management identified a material weakness in internal controls over financial reporting as of September 30, 2024.
- The company intends to restate unaudited condensed interim financial statements for the Non-Reliance Periods.
Chain Bridge I has terminated its business combination agreement with Phytanix Bio and simultaneously replaced its independent auditor. The company also disclosed a material weakness in internal controls leading to the need for a restatement of previously issued financial statements.
🚩 Red Flags
- Termination of a material business combination agreement (failed SPAC merger).
- Auditor change combined with restatement (High-risk indicator).
- Material weakness in internal controls over financial reporting.
- Financial statements for the Non-Reliance Periods can no longer be relied upon.
📋 Key Facts
- Termination Agreement signed on April 7, 2025, terminating the Business Combination Agreement with Phytanix Bio dated July 22, 2024.
- Auditor change: Frank, Rimerman & Co. LLP terminated; RBSM, LLP engaged as new independent auditor effective April 4, 2025.
- Material weakness identified in internal controls over financial reporting as of September 30, 2024.
- Restatement required for unaudited condensed interim financial statements for the three and nine month periods ended September 30, 2024 (Non-Reliance Periods).
- Error involves understating a $200,000 liability related to a Bridge Financing Note from June 26, 2024.
Chain Bridge I has announced that its unaudited consolidated interim financial statements for the periods ended September 30, 2024, should no longer be relied upon due to an error in reporting a promissory note liability. The error resulted from understating a $200,000 liability related to Phytaix Bio, leading to understated expenses and overstated net income.
🚩 Red Flags
- Restatement of previously issued financial statements (Item 4.02)
- Identification of a material weakness in internal control over financial reporting
- Ineffective disclosure controls and procedures
- Error involves an understatement of liabilities/overstatement of income, which can impact investor perception of profitability.
📋 Key Facts
- The Audit Committee concluded on January 23, 2025, that the unaudited consolidated interim financial statements for the three and nine month periods ended September 30, 2024, are unreliable.
- An error understated a promissory note liability (Bridge Financing Note) dated June 26, 2024, by $200,000.
- The error caused an understatement of general and administrative expenses and an overstatement of net income for the Non-Reliance Periods.
- Management identified a material weakness in internal control over financial reporting related to the review and reconciliation of liabilities.
- Disclosure controls and procedures were determined to be ineffective for the Non-Reliance Periods.
- The restatement has no impact on the Company's cash position or Trust Account amount.
Chain Bridge I is being delisted from the Nasdaq and will transition to trading on the OTCQB market under symbol CBRRF. Shareholders also approved an extension of the deadline to complete a business combination to November 15, 2025.
🚩 Red Flags
- Delisting from Nasdaq to OTC markets (loss of liquidity/prestige).
- Failure to meet original business combination deadline necessitated an extension.
- Risk of liquidation if the Phytanix Business Combination is not consummated.
- Warrants could expire worthless in a liquidation scenario.
📋 Key Facts
- Nasdaq suspension of Class A ordinary shares and units is effective November 19, 2024.
- Securities will move to OTCQB (CBRRF) and Pink Open Market (CBRGF/CBGGF).
- Shareholders approved an amendment to extend the deadline for a business combination from Nov 15, 2024, to Nov 15, 2025.
- Redemptions occurred: 550,947 Class A shares were redeemed for ~$6.34 million in cash.
- Post-redemption outstanding Class A Ordinary Shares: 3,014,736.
Chain Bridge I has received a delisting notice from Nasdaq because it failed to complete a business combination within the required 36-month window. Trading is scheduled to be suspended on November 19, 2024.
🚩 Red Flags
- Delisting notice from Nasdaq (Rule IM-5101-2)
- Failure to complete business combination within the mandatory 36-month timeframe
- Imminent suspension of trading (Nov 19, 2024)
- Liquidity risk: Company warns shareholders may not be able to sell shares in the open market even if price exceeds redemption value.
📋 Key Facts
- Nasdaq issued a letter stating securities will be delisted pursuant to Rule IM-5101-2.
- Trading of Class A common stock and units is expected to be suspended at the opening of business on November 19, 2024.
- The company failed to complete its initial business combination by the November 4, 2024 deadline.
- A Form 25-NSE will be filed with the SEC to remove securities from listing and registration.
- Backstop Investors entered into an amendment allowing them to purchase Acquired Shares prior to the shareholder meeting on November 14, 2024.
Chain Bridge I (a SPAC) has received notice from Nasdaq of its intent to suspend and delist the company's Class A Shares and Units. This follows the expiration of the 36-month deadline to complete a business combination on November 9, 2024.
🚩 Red Flags
- Imminent delisting from Nasdaq (Notice expected Nov 12, 2024).
- Failure to complete a business combination within the required 36-month window.
- Extreme liquidity risk and potential for significant loss of market quotation availability.
- The company is in an 'extension' phase attempting to avoid liquidation/winding up.
📋 Key Facts
- Nasdaq informed the Company on November 11, 2024, of its intent to deliver a delisting notice on November 12, 2024.
- The company's IPO registration statement deadline for completing a business combination was November 9, 2024.
- The company has entered into non-redemption agreements with 'Backstop Investors' to rescind previous redemption elections for up to 429,180 shares.
- Backstop Investors agree to hold and not redeem 128,753 shares at the closing of a potential De-Spac Transaction.
- The company is attempting to move its listing to the OTCQB, though approval is not guaranteed.
Chain Bridge I has postponed its Extraordinary General Meeting (EGM) from November 8, 2024, to November 14, 2024. The meeting is intended to vote on a critical amendment to extend the deadline for completing a business combination from November 15, 2024, to November 15, 2025.
🚩 Red Flags
- Imminent expiration of business combination deadline (Nov 15, 2024).
- Risk of mandatory liquidation/dissolution if the extension is not approved or a deal is not found.
- Postponement of shareholder vote suggests ongoing difficulty in securing sufficient proxy solicitations or finalizing terms.
📋 Key Facts
- Postponement of EGM originally scheduled for Nov 8, 2024, to Nov 14, 2024.
- The meeting aims to vote on an 'Amendment Proposal' to extend the business combination deadline by one year (to Nov 15, 2025).
- Redemption deadline for Class A ordinary shares has been extended to 5:30 p.m. ET on November 12, 2024.
- Failure to complete a merger/acquisition by the current deadline (Nov 15, 2024) would trigger mandatory liquidation and dissolution.
Chain Bridge I has entered into a Dissolution Expense Reimbursement Agreement with its sponsor, Fulton AC I LLC. This agreement provides for the reimbursement of up to $100,000 in dissolution expenses from the trust account upon liquidation.
🚩 Red Flags
- Dissolution Agreement: The existence of a formal agreement to fund dissolution expenses strongly indicates that the SPAC (Special Purpose Acquisition Company) has failed to complete a business combination and is moving toward liquidation.
- Liquidation Imminent: This filing is a precursor to the wind-down of the entity.
📋 Key Facts
- Agreement Date: October 29, 2024
- Parties: Chain Bridge I (the Company) and Fulton AC I LLC (CBRG Sponsor)
- Reimbursement Amount: Up to $100,000
- Purpose: To pay dissolution expenses if and when the Company is dissolved.
- Impact on Liquidation: Reimbursements will be included in the amount distributable to Class A Ordinary Shareholders during liquidation.
Chain Bridge I has regained compliance with Nasdaq's Public Shareholder Rule (Listing Rule 5550(a)(3)). This follows a non-compliance notice received on June 20, 2024.
🚩 Red Flags
- Previous non-compliance with Nasdaq listing requirements (Public Shareholder Rule).
📋 Key Facts
- Nasdaq notified the company on September 13, 2024, that it has regained compliance with the Public Shareholder Rule.
- The rule requires the company to maintain a minimum of 300 public holders.
- Non-compliance was previously disclosed in a notice from Nasdaq dated June 20, 2024.
Chain Bridge I (a SPAC) has entered into a definitive Business Combination Agreement with Phytanix Bio to complete a merger. The company furnished an investor presentation on July 29, 2024, to support the transaction.
🚩 Red Flags
- SPAC structure carries inherent risks regarding shareholder redemption requests.
- Potential for significant dilution via warrants and new equity issuance in the pro forma structure.
- Risk of failure to meet stock exchange listing standards post-combination.
📋 Key Facts
- Entered into a Business Combination Agreement on July 22, 2024.
- Target company is Phytanix Bio, a Nevada corporation.
- The deal involves HoldCo, CB Merger Sub 1 (Cayman Islands), and CB Merger Sub 2 (Nevada).
- An investor presentation was furnished on July 29, 2024, under Item 7.01.
- A Registration Statement on Form S-4 will be filed by HoldCo to facilitate the merger.
Chain Bridge I (CBRRF) has entered into a definitive Business Combination Agreement with Phytanix Bio to complete a SPAC merger. The transaction is expected to close in Q4 2024, resulting in the combined entity being renamed Phytanix, Inc. and trading on Nasdaq under the ticker 'PHYX'.
🚩 Red Flags
- SPAC merger structure (historically higher volatility and dilution risk).
- Closing is contingent upon a $100 million equity line of credit, indicating potential liquidity dependency.
- Subject to shareholder approval from both CBRG and the target company.
📋 Key Facts
- Transaction value: Aggregate consideration derived from an equity value of $58 million.
- Expected closing date: Fourth quarter of 2024.
- New Entity Name/Ticker: Phytanix, Inc. / PHYX.
- Structure: Merger involving CB Holdings, Inc., CBRG, and Phytanix Bio via merger subs.
- Financing Condition: Closing is subject to an agreement providing for a $100 million equity line of credit with Keystone Capital Partners, LLC or its affiliates.
- Board Composition: Post-merger board will consist of up to seven directors divided into three classes.
Chain Bridge I has entered into a $1.59 million unsecured, non-interest bearing bridge financing note with Phytanix Bio to fund working capital and business combination expenses.
🚩 Red Flags
- High reliance on external bridge financing for working capital suggests limited cash runway
- The debt is tied to the consummation of a business combination, indicating an urgent need for liquidity to reach a merger/acquisition target
- Unsecured nature of the note increases risk for lenders and potential dilution or restructuring implications for shareholders
📋 Key Facts
- Loan amount: $1,590,995.12
- Lender: Phytanix Bio
- Terms: Unsecured, non-interest bearing promissory note
- Maturity Date: The later of June 29, 2025, or the consummation of the Company's initial business combination
- Use of proceeds: Repay working capital loans to Fulton AC I LLC, pay fees/expenses related to the bridge financing and business combination, and general corporate purposes
- Restriction: Proceeds cannot be repaid using funds from the company's trust account
Chain Bridge I received a notice from Nasdaq stating it is non-compliant with the minimum requirement of 300 public holders (Listing Rule 5550(a)(3)). The company has until August 5, 2024, to submit a plan to regain compliance.
🚩 Red Flags
- Delisting notice regarding minimum public holder requirements
- Risk of losing Nasdaq listing if compliance is not achieved within the grace period
📋 Key Facts
- Received written notice from Nasdaq on June 20, 2024.
- Non-compliance is specifically regarding Listing Rule 5550(a)(3) (minimum of 300 public holders).
- The company has a 45-day deadline (until August 5, 2024) to submit a compliance plan.
- If the plan is accepted, the company has 180 days to demonstrate compliance.
- Failure to regain compliance within the 180-day period may lead to delisting.
Chain Bridge I announced the immediate resignation of CFO Roger Lazarus on April 1, 2024. He is being replaced by Andrew Kucharchuk, who will serve under a consulting agreement with the company's controlling stockholder.
🚩 Red Flags
- Immediate departure of the CFO can indicate internal friction or unforeseen issues.
- The new CFO's compensation is paid by a controlling stockholder (Fulton AC I LLC) rather than the company itself, creating potential conflicts of interest and complex governance structures.
- New officer is subject to transfer restrictions via a Letter Agreement with insiders/controlling stockholders.
📋 Key Facts
- Roger Lazarus resigned as CFO effective April 1, 2024; he will remain an advisor through the end of April 2024 for transition purposes.
- Andrew Kucharchuk appointed as new CFO effective April 1, 2024.
- Kucharchuk's compensation is governed by a consulting agreement with Fulton AC I LLC (a controlling stockholder), not directly by the Company.
- Compensation includes $7,500 upon execution and $7,500 per month through August 31, 2024, plus potential discretionary bonuses from Fulton.
- Kucharchuk is subject to a Letter Agreement dated November 9, 2021, which includes transfer restrictions on Company securities.
Chain Bridge I announced the appointment of Oliver Wiener to its Board of Directors and Audit Committee, resulting in an increase in board size to five members. Concurrently, Daniel Wainstein resigned from the Audit Committee.
🚩 Red Flags
- Resignation of an Audit Committee member (Daniel Wainstein), though this appears to be a routine replacement due to the new appointment.
📋 Key Facts
- Oliver Wiener appointed as a Class II director on February 21, 2024.
- Mr. Wiener is deemed 'independent' and will serve on the Audit Committee.
- Board size increased to five directors following this appointment.
- Daniel Wainstein resigned from the Audit Committee.
- The Company agreed to grant Mr. Wiener 50,000 restricted stock units (RSUs) to be issued after an initial business combination and shareholder approval of an equity incentive plan.
- Mr. Wiener will receive no compensation prior to the consummation of a business combination.
Chain Bridge I held an Extraordinary General Meeting where shareholders approved an amendment to extend the company's termination date from February 15, 2024, to November 15, 2024. This extension provides more time for the SPAC to complete a business combination before being forced to liquidate.
🚩 Red Flags
- Significant redemption event: Over $34.5 million was redeemed from the Trust Account, leaving a much smaller capital base for a potential business combination.
- The company is operating under an extension to avoid mandatory liquidation (winding up) scheduled for February 2024.
- High ratio of Class B shares remaining relative to Class A shares post-redemption, which may impact future dilution or control structures.
📋 Key Facts
- Shareholders approved an amendment to extend the 'Termination Date' from February 15, 2024, to November 15, 2024.
- Redemptions occurred for 3,144,451 Class A Shares, totaling approximately $34,530,234.77 in cash from the Trust Account.
- Fulton AC will contribute $22,500 to the Trust on February 16, 2024, plus $5,000 per month starting May 16, 2024, until a business combination or liquidation occurs.
- Class B Ordinary Shares held by Chain Bridge Group and CB Co-Investment (2,559,000 shares) were converted to Class A Ordinary Shares upon approval of the amendment.
- Post-redemption/conversion outstanding shares: 3,565,683 Class A Ordinary Shares and 3,191,000 Class B Ordinary Shares.
This 8-K/A amendment provides updated disclosure regarding a massive overhaul of the company's leadership. The entire Board and all officers (except the CFO) resigned, replaced by a new slate of directors and a new CEO.
🚩 Red Flags
- Total turnover of management and Board: The resignation of all officers and the entire Board is an extreme governance event.
- Concentrated voting power: New directors are bound by letter agreements to vote in favor of a specific business combination, limiting independent shareholder influence.
📋 Key Facts
- Effective as of the Closing Date, all officers except the CFO resigned.
- The entire existing Board of Directors resigned.
- Andrew Cohen was appointed as Chief Executive Officer.
- The Board size was decreased from five members to four.
- New directors include Andrew Cohen, Daniel Wainstein, Lewis Silberman, and Paul Baron.
- The company entered into RSU agreements for Mr. Silberman (50,000 units), Mr. Baron (50,000 units), and Mr. Lazarus (70,000 units).
- New directors agreed to vote Class B and Class A shares in favor of the initial business combination.
The Company's Board of Directors approved an extension of its business operations for one month, until February 15, 2024. This is a typical procedural filing for a SPAC (Special Purpose Acquisition Company) approaching its liquidation deadline.
🚩 Red Flags
- Approaching liquidation deadline (February 15, 2024) suggests a failure to complete a business combination within the original timeframe.
- The company is operating under an extension, indicating high pressure to find a target or liquidate.
📋 Key Facts
- Board approved extending business operations by one month.
- New expiration date for business operations: February 15, 2024.
- The extension was made in accordance with the Company's Amended and Restated Memorandum and Articles of Association.
Chain Bridge I, a SPAC, has undergone significant restructuring including the resignation of its entire Board and officer suite (except the CFO), an extension of its business combination deadline to November 15, 2024, and the execution of several related-party agreements with Fulton AC I LLC.
🚩 Red Flags
- Mass resignation of the Board and nearly all officers indicates significant internal instability or a complete change in control/direction.
- Heavy reliance on related-party financing ($1.5M note from Fulton AC I LLC) and services agreements ($30k/month).
- The extension of the termination date to November 2024 suggests the company is struggling to find a target or complete a merger within the original timeframe.
- Potential dilution through the issuance of warrants and conversion of Class B shares.
📋 Key Facts
- Business combination deadline extended from February 15, 2024, to November 15, 2024.
- Fulton AC I LLC agreed to loan the Company up to $1.5 million via an unsecured non-interest bearing convertible promissory note.
- The Board of Directors was decreased from five members to four; all previous officers (except CFO) and the entire Board resigned.
- Andrew Cohen appointed as new CEO.
- Fulton AC I LLC entered into a Services Agreement to provide office space and administrative services for $30,000 per month.
- Sellers agreed to convert Class B Ordinary Shares into Class A Ordinary Shares upon approval of the Amendment Proposal.